SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners today announced that Jim Brady has been named an Operating Partner on the firm’s Growth Buyout team.
Mr. Brady brings almost 30 years of experience in healthcare as both an Operating Partner in private equity as well as an executive operator in software and technology. Most recently Mr. Brady was Healthcare Operating Partner at Marlin Equity Partners where he helped create and build a highly successful portfolio including over 20 acquisitions across multiple sectors within healthcare.
“We are thrilled that Jim has chosen to join Frazier as the firm looks to build its presence in healthcare IT. His tenured background in the healthcare information technology industry, as well as his proven leadership experience, will greatly enhance our investing efforts in the sector,” said Frazier General Partner Ben Magnano.
About Mr. Brady:
Before joining Marlin, Mr. Brady had extensive executive experience as an operator in the healthcare IT and services sectors, including as founder of a successful entrepreneurial startup venture and executive roles with a number of public companies. Mr. Brady was the founder and CEO of Payerpath, a web-based claims management system for healthcare providers and payers founded in the late 1990s. In 2006, Payerpath was sold to Misys Healthcare Systems, one of the top five healthcare IT companies in North America. After the sale of Payerpath, Mr. Brady served as President of Payerpath, a Misys Company, and served on the Board of Misys Healthcare Systems as well as on the Operating Board of its parent company, UK-based Misys plc. Prior to founding Payerpath, Mr. Brady was Vice President of Sales for NDC Health as well as Senior Vice President of Health Communication Services. He started his career at ADP.
Mr. Brady holds a B.A. degree in Economics from the University of Richmond.
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $4.2 billion in total capital raised, Frazier has invested in more than 170 companies with investments ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, Wash., and Menlo Park, Calif., and invests broadly across the U.S., Canada and Europe.
For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.
